Publications found:
36,694
Sort by:
Automated Breast Ultrasound Systems Market - 2024-2031
US$ 3,400.00
Automated Breast Ultrasound Systems Market reached USD 14,24 million in 2023 and is expected to reach USD 2452 million by 2031, growing with a CAGR of 12.40% during the forecast period 2026-2031. The...
February 2024
61 pages
Zoladex Market - 2024-2031
US$ 3,400.00
Zoladex Marketis is growing with a CAGR of 1.40% during the forecast period 2026-2035. The Zoladex Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned research...
February 2024
33 pages
Parenteral Nutrition Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)
US$ 5,190.00
The parenteral nutrition market size was valued at US$ 6.84 billion in 2022 and is expected to reach US$ 11.21 billion by 2030. The market is estimated to register a CAGR of 6.2% from 2022 to 2030. Pa...
February 2024
154 pages
Arthritic Therapeutic Market By Product Type (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, Others), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Others): Global Opportunity Analysis and Industry Forecast, 2022 - 2032
US$ 3,570.00
The arthritic therapeutic market was valued at $79.5 billion in 2022 and is estimated to reach $136.1 billion by 2032, exhibiting a CAGR of 5.5% from 2023 to 2032. Arthritis therapeutics involves a co...
February 2024
250 pages
Pregabalin Market By Type (Tablets and Capsules, Others), By Application (Epilepsy, Neuropathic Pain, Others), By Distribution Channel (Hospital Pharmacies, Drug Store and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2022 - 2032
US$ 3,570.00
The pregabalin market was valued at $1.6 billion in 2022 and is estimated to reach $2.2 billion by 2032, exhibiting a CAGR of 3% from 2023 to 2032. Pregabalin belongs to a group of drugs known as anti...
February 2024
289 pages
Dependent Insulinotropic Receptor Market - 2024-2031
US$ 3,400.00
The Dependent Insulinotropic Receptor Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight t...
February 2024
59 pages
Immunosuppressants Drugs Market - 2024-2031
US$ 3,400.00
Immunosuppressants Drugs Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Immunosuppressants Drugs Market emerges as a key focus in DataM Intelligence latest in-depth...
February 2024
50 pages
Platinum Based Cancer Drug Market - 2024-2031
US$ 3,400.00
Platinum Based Cancer Drug Marketis is growing with a CAGR of 3.20% during the forecast period 2026-2035. The Platinum Based Cancer Drug Market emerges as a key focus in DataM Intelligence latest in-d...
February 2024
52 pages
Formulation Development Outsourcing Market - 2024-2031
US$ 3,400.00
The Formulation Development Outsourcing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
February 2024
61 pages
Smoking Cessation Aids Market - 2024-2031
US$ 3,400.00
The Smoking Cessation Aids Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
February 2024
48 pages
Blood Plasma Derivatives Market - 2024-2031
US$ 3,400.00
Blood Plasma Derivatives Marketis is growing with a CAGR of 4.30% during the forecast period 2026-2035. The Blood Plasma Derivatives Market emerges as a key focus in DataM Intelligence latest in-depth...
January 2024
50 pages
Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028
US$ 2,970.00
The global theranostics market is projected to reach USD 4.3 billion by 2028 from USD 2.1 billion in 2023, at a CAGR of 15.5% from 2023 to 2028. Factors such as rising baby boomer population and advan...
January 2024
194 pages
Pompe Disease Treatment Market by Treatment (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Chaperone-Advanced Replacement Therapy (CART), and Others), Route of Administration (Oral, Intravenous, and Others), Distribution Channel (Hospital and Clinics Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Indication Type (Infantile-Onset Pompe Disease (IOPD), Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Pompe Disease (LOPD), and Others), and Region 2024-2032
US$ 2,999.00
The global Pompe disease treatment market size reached US$ 1.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.5...
January 2024
142 pages
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032
US$ 2,999.00
The global systemic lupus erythematosus (SLE) drugs market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth r...
January 2024
142 pages
Analgesics Market Report by Type (Prescription, Over-The-Counter (OTC)), Drug Class (Opioids, NSAIDs, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns, Dental/Facial, Pediatric, and Others), Application (Internal, External), and Region 2024-2032
US$ 2,999.00
The global analgesics market size reached US$ 54.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 77.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 20...
January 2024
149 pages
Human Insulin Market Report by Product Type (Drugs, Delivery Devices), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Retail Stores, and Others), Disease Type (Type I Diabetes, Type II Diabetes), and Region 2024-2032
US$ 2,999.00
The global human insulin market size reached US$ 48.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 84.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during...
January 2024
149 pages
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
US$ 2,999.00
The US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 202...
January 2024
139 pages
Emtricitabine and Tenofovir Market - 2024-2031
US$ 3,400.00
Emtricitabine and Tenofovir Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Emtricitabine and Tenofovir Market emerges as a key focus in DataM Intelligence latest in...
January 2024
53 pages
Global Battery Pasting Papers Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Battery Pasting Papers market size is predicted to grow from US$ 118 million in 2025 to US$ 156 mi...
January 2024
118 pages
Global Aminoglycosides Antibiotics Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Aminoglycosides Antibiotics market size is predicted to grow from US$ 717 million in 2025 to US$ 6...
January 2024
119 pages
Global Alvimopan Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Alvimopan market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is...
January 2024
76 pages
Global Carboplatin Crystal Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Carboplatin Crystal market size is predicted to grow from US$ million in 2025 to US$ million in 20...
January 2024
91 pages
Global Cloakroom Room Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Cloakroom Room market size is predicted to grow from US$ million in 2025 to US$ million in 2031; i...
January 2024
132 pages
Global Drogue Parachutes Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Drogue Parachutes market size is predicted to grow from US$ million in 2025 to US$ million in 2031...
January 2024
80 pages
Global Markets for Vaccine Technologies
US$ 4,650.00
... tables An overview of the global market for vaccine technologies Analyses of global market trends, with data from 2016 ... animals) and disease indications (infectious, cancer, and allergy) Examination of the industry environment, strategies, market influences, and driving forces Identification of regional market ...
January 2024
213 pages
Infectious Disease Therapeutics Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti-bacterial, Anti-fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
US$ 5,190.00
The infectious disease therapeutics market was valued at US$ 119.708 billion in 2022 and is expected to reach US$ 167.883 billion by 2030. The market is estimated to register a CAGR of 4.3% from 2022...
January 2024
193 pages
Oncology Based In-Vivo CRO Market - 2024-2031
US$ 3,400.00
The Oncology Based In-Vivo CRO Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
January 2024
52 pages
Plasma Protein Therapeutics Market - 2024-2031
US$ 3,400.00
The Plasma Protein Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
January 2024
53 pages
Pregabalin Market - 2024-2031
US$ 3,400.00
The Pregabalin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
January 2024
36 pages
Ampicillin Market - 2024-2031
US$ 3,400.00
The Ampicillin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
January 2024
36 pages
Anosmia Market - 2024-2031
US$ 3,400.00
The Anosmia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled mar...
January 2024
33 pages
Hereditary Angioedema Therapeutics Market - 2024-2031
US$ 3,400.00
Hereditary Angioedema Therapeutics Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Hereditary Angioedema Therapeutics Market emerges as a key focus in DataM Intellig...
January 2024
60 pages
Short-Acting Insulin Market - 2024-2031
US$ 3,400.00
The Short-Acting Insulin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
January 2024
46 pages
Urea Cycle Disorder Treatment Market - 2024-2031
US$ 3,400.00
The Urea Cycle Disorder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
January 2024
55 pages
Minoxidil Market - 2024-2031
US$ 3,400.00
Minoxidil Marketis is growing with a CAGR of 4.70% during the forecast period 2026-2035. The Minoxidil Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned rese...
January 2024
35 pages
Oxaliplatin Market - 2024-2031
US$ 3,400.00
The Oxaliplatin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
January 2024
37 pages
Global Influenza Vaccines Market and Forecasts 2024 – 2032
US$ 3,500.00
The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period. Several factors ar...
January 2024
310 pages
Lipid Disorder Treatment Market - 2024-2031
US$ 3,400.00
The Lipid Disorder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
January 2024
50 pages
Plasma Protease C1-Inhibitor Treatment Market - 2024-2031
US$ 3,400.00
The Plasma Protease C1-Inhibitor Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
January 2024
64 pages
Appendix Cancer Drugs Market - 2024-2031
US$ 3,400.00
The Appendix Cancer Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver un...
January 2024
47 pages
Cancer Angiogenesis Inhibitors Market - 2024-2031
US$ 3,400.00
The Cancer Angiogenesis Inhibitors Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
January 2024
56 pages
Cancer Anorexia-Cachexia Syndrome Drug Market - 2024-2031
US$ 3,400.00
The Cancer Anorexia-Cachexia Syndrome Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
January 2024
64 pages
Differentiated Thyroid Cancer Drugs Market - 2024-2031
US$ 3,400.00
The Differentiated Thyroid Cancer Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
January 2024
61 pages
Myeloproliferative Disorders Drugs Market - 2024-2031
US$ 3,400.00
Myeloproliferative Disorders Drugs Marketis is growing with a CAGR of 4.10% during the forecast period 2026-2035. The Myeloproliferative Disorders Drugs Market emerges as a key focus in DataM Intellig...
January 2024
60 pages
Plant Sources Anti-Cancer Agents Market - 2024-2031
US$ 3,400.00
The Plant Sources Anti-Cancer Agents Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
January 2024
58 pages
Sunitinib Malate Market - 2024-2031
US$ 3,400.00
The Sunitinib Malate Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparal...
January 2024
42 pages
